Ampicillin: Difference between revisions
(Created page with "==General== *Type: *Dosage Forms: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Pregnancy: *Lactation: *Renal Dosing **Adult **Pedia...") |
Ostermayer (talk | contribs) No edit summary |
||
| (14 intermediate revisions by 8 users not shown) | |||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: | Ampicillin is an antibiotic in the beta-lactam family of antibiotics. It is a Penicillin derivative. | ||
*Dosage Forms: | |||
*Common Trade Names: | *Type: [[Is PenicillinType::Amino]]-[[Is DrugClass::Penicillin]] | ||
*Dosage Forms: capsule, oral suspension, powder for injection | |||
*Dosage Strengths: capsule: 250, 500mg; oral suspension: 125, 250mg/5mL; powder for injection: 125mg, 250mg, 500mg, 1g, 2g, 10g | |||
*Routes of Administration: PO, IV, IM | |||
*Common Trade Names: Ampi, Omnipen, Penglobe, Principen | |||
==Adult Dosing== | ==Adult Dosing== | ||
===Endocarditis=== | |||
*12 g daily (continuous IV infusion or in 6 equally divided dosages) in conjunction with gentamicin | |||
===Perinatal Group B Streptococcal Prevention=== | |||
*Initial 2 g dose at time of labor or rupture of membranes, followed by 1 g q4hrs until delivery | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===[[Pneumonia (peds)]]=== | |||
*150-200mg/kg/day IV divided Q6hours (max dose: 4g per day) | |||
===Other Pediatric Bacterial Infections=== | |||
*100-400mg/kg/day IM/IV divided q4-16Hours (max dose 12g/day IM/IV) | |||
==Special Populations== | ==Special Populations== | ||
*Pregnancy: | *[[Drug pregnancy categories|Pregnancy Rating]]: B | ||
*Lactation: | *Lactation: Excreted in breastmilk, use caution | ||
*Renal | *Renal dosing: | ||
** | **CrCl <10 mL/min: Administer q12-24hr | ||
** | **CrCl 10-50 mL/min: Administer q6-12hr | ||
* | **CrCl >50 mL/min: Administer q6hr | ||
* | *Hepatic Dosing: not studied | ||
* | |||
==Contraindications== | ==Contraindications== | ||
| Line 23: | Line 37: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Pseudomembranous colitis, enterocolitis | |||
*Agranulocytosis | |||
*Seizure | |||
*Interstitial nephritis | |||
*Stridor | |||
*Anaphylaxis | |||
===Common=== | ===Common=== | ||
*Rash, urticaria | |||
*Diarrhea, nausea | |||
*Fever | |||
*Oral candidiasis | |||
*Stomatitis, glossitis | |||
*Anemia/hemolytic anemia, leukopenia, thrombocytopenia, eosinophilia | |||
*Serum sickness like reaction | |||
*Elevated AST | |||
*Erythema multiforme | |||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Half-life: 1-1.8 hr (normal renal function); 7-20 hr (anuria/ESRD) | ||
*Metabolism: | *Metabolism: Hepatic | ||
*Excretion: | *Excretion: Urine | ||
*Mechanism of Action: | *Mechanism of Action: Bactericidal; inhibits bacterial cell wall synthesis | ||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | |||
{| class="wikitable" | |||
| align="center" style="background:#f0f0f0;"|'''Group''' | |||
| align="center" style="background:#f0f0f0;"|'''Organism''' | |||
| align="center" style="background:#f0f0f0;"|'''Sensitivity''' | |||
|- | |||
| Gram Positive||[[Strep. Group A, B, C, G]]||'''S''' | |||
|- | |||
| ||[[Strep. Pneumoniae]]||'''S''' | |||
|- | |||
| ||[[Viridans strep]]||I | |||
|- | |||
| ||Strep. anginosus gp||'''S''' | |||
|- | |||
| ||[[Enterococcus faecalis]]||'''S''' | |||
|- | |||
| ||[[Enterococcus faecium]]||I | |||
|- | |||
| ||[[MSSA]]||R | |||
|- | |||
| ||[[MRSA]]||R | |||
|- | |||
| ||[[CA-MRSA]]||R | |||
|- | |||
| ||[[Staph. Epidermidis]]||R | |||
|- | |||
| ||[[C. jeikeium]]||R | |||
|- | |||
| ||[[L. monocytogenes]]||'''S''' | |||
|- | |||
| Gram Negatives||[[N. gonorrhoeae]]||R | |||
|- | |||
| ||[[N. meningitidis]]||'''S''' | |||
|- | |||
| ||[[Moraxella catarrhalis]]||R | |||
|- | |||
| ||[[H. influenzae]]||I | |||
|- | |||
| ||[[E. coli]]||I | |||
|- | |||
| ||[[Klebsiella]] sp||R | |||
|- | |||
| ||E. coli/Klebsiella ESBL+||R | |||
|- | |||
| ||E coli/Klebsiella KPC+||R | |||
|- | |||
| ||[[Enterobacter]] sp, AmpC neg||R | |||
|- | |||
| ||[[Enterobacter]] sp, AmpC pos||R | |||
|- | |||
| ||[[Serratia]] sp||R | |||
|- | |||
| ||Serratia marcescens||X1 | |||
|- | |||
| ||[[Salmonella]] sp||I | |||
|- | |||
| ||[[Shigella]] sp||I | |||
|- | |||
| ||[[Proteus mirabilis]]||'''S''' | |||
|- | |||
| ||[[Proteus vulgaris]]||R | |||
|- | |||
| ||[[Providencia sp.]]||R | |||
|- | |||
| ||[[Morganella sp.]]||R | |||
|- | |||
| ||[[Citrobacter freundii]]||R | |||
|- | |||
| ||[[Citrobacter diversus]]||R | |||
|- | |||
| ||[[Citrobacter sp.]]||R | |||
|- | |||
| ||[[Aeromonas sp]]||R | |||
|- | |||
| ||[[Acinetobacter sp.]]||R | |||
|- | |||
| ||[[Pseudomonas aeruginosa]]||R | |||
|- | |||
| ||[[Burkholderia cepacia]]||R | |||
|- | |||
| ||[[Stenotrophomonas maltophilia]]||R | |||
|- | |||
| ||[[Yersinia enterocolitica]]||R | |||
|- | |||
| ||[[Francisella tularensis]]||X1 | |||
|- | |||
| ||[[Brucella sp.]]||X1 | |||
|- | |||
| ||[[Legionella sp.]]||R | |||
|- | |||
| ||[[Pasteurella multocida]]||'''S''' | |||
|- | |||
| ||[[Haemophilus ducreyi]]||R | |||
|- | |||
| ||[[Vibrio vulnificus]]||X1 | |||
|- | |||
| Misc||[[Chlamydophila sp]]||R | |||
|- | |||
| ||[[Mycoplasm pneumoniae]]||R | |||
|- | |||
| ||[[Rickettsia sp]]||X1 | |||
|- | |||
| ||[[Mycobacterium avium]]||X1 | |||
|- | |||
| Anaerobes||[[Actinomyces]]||'''S''' | |||
|- | |||
| ||[[Bacteroides fragilis]]||R | |||
|- | |||
| ||[[Prevotella melaninogenica]]||'''S''' | |||
|- | |||
| ||[[Clostridium difficile]]||X1 | |||
|- | |||
| ||[[Clostridium (not difficile)]]||'''S''' | |||
|- | |||
| ||[[Fusobacterium necrophorum]]||'''S''' | |||
|- | |||
| ||[[Peptostreptococcus sp.]]||'''S''' | |||
|} | |||
===Key=== | |||
{{Template:Antibacterial Spectra Key}} | |||
==See Also== | ==See Also== | ||
*[[Antibiotics (Main)]] | *[[Antibiotics (Main)]] | ||
== | ==References== | ||
<references/> | <references/> | ||
[[Category: | [[Category:Pharmacology]] [[Category:ID]] | ||
Latest revision as of 17:42, 18 July 2025
General
Ampicillin is an antibiotic in the beta-lactam family of antibiotics. It is a Penicillin derivative.
- Type: Amino-Penicillin
- Dosage Forms: capsule, oral suspension, powder for injection
- Dosage Strengths: capsule: 250, 500mg; oral suspension: 125, 250mg/5mL; powder for injection: 125mg, 250mg, 500mg, 1g, 2g, 10g
- Routes of Administration: PO, IV, IM
- Common Trade Names: Ampi, Omnipen, Penglobe, Principen
Adult Dosing
Endocarditis
- 12 g daily (continuous IV infusion or in 6 equally divided dosages) in conjunction with gentamicin
Perinatal Group B Streptococcal Prevention
- Initial 2 g dose at time of labor or rupture of membranes, followed by 1 g q4hrs until delivery
Pediatric Dosing
Pneumonia (peds)
- 150-200mg/kg/day IV divided Q6hours (max dose: 4g per day)
Other Pediatric Bacterial Infections
- 100-400mg/kg/day IM/IV divided q4-16Hours (max dose 12g/day IM/IV)
Special Populations
- Pregnancy Rating: B
- Lactation: Excreted in breastmilk, use caution
- Renal dosing:
- CrCl <10 mL/min: Administer q12-24hr
- CrCl 10-50 mL/min: Administer q6-12hr
- CrCl >50 mL/min: Administer q6hr
- Hepatic Dosing: not studied
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Pseudomembranous colitis, enterocolitis
- Agranulocytosis
- Seizure
- Interstitial nephritis
- Stridor
- Anaphylaxis
Common
- Rash, urticaria
- Diarrhea, nausea
- Fever
- Oral candidiasis
- Stomatitis, glossitis
- Anemia/hemolytic anemia, leukopenia, thrombocytopenia, eosinophilia
- Serum sickness like reaction
- Elevated AST
- Erythema multiforme
Pharmacology
- Half-life: 1-1.8 hr (normal renal function); 7-20 hr (anuria/ESRD)
- Metabolism: Hepatic
- Excretion: Urine
- Mechanism of Action: Bactericidal; inhibits bacterial cell wall synthesis
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014
